Medscape2 个月
Balancing Diuretic Therapy in Heart Failure: Loop Diuretics, Thiazides, and Aldosterone ...
Although diuretics do not directly treat the pathologic changes that occur with heart failure, they are the mainstay of symptomatic treatment to remove excess extracellular fluid, thus alleviating ...
pharmaphorum4 天
FDA fast-tracks AskBio’s heart failure gene therapy
A gene therapy for heart failure being developed by Bayer’s ... therapy or a placebo administered via intracoronary artery infusion. The main outcome measures are cardiovascular death and ...
First Participant Randomized in AskBio European Phase 2 Gene Therapy Trial for Congestive ...
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart ...
pharmaphorum8 天
AHA: First data backs AskBio’s heart failure gene therapy
Bayer’s AskBio unit has reported the first clinical data for its congestive heart failure gene therapy ... given as a single intracoronary artery infusion to people with NYHA Class III heart ...
Pharmabiz6 天
AskBio announces first participant randomized in Europe in GenePHIT phase 2 trial of AB ...
Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...
Finanznachrichten8 天
Asklepios BioPharmaceutical, Inc. (AskBio): First Participant Randomized in AskBio European ...
13, 2025 (GLOBE NEWSWIRE) -- AB-1002 is an investigational gene therapy for the treatment of adults ... evaluate the safety and efficacy of a single intracoronary infusion of AB-1002 in adults with ...